Anita B. Gothelf
Copenhagen, 2100, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Prognostic significance of p16 and immune cell infiltration in recurrent/metastatic head and neck squamous cell carcinoma treated with PD-1 inhibition: a national DAHANCA cohort study.
Journal: Oral oncology
Published: October 10, 2025
Pembrolizumab as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multi-institutional DAHANCA cohort study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: July 07, 2025
Initial cosmetic outcome six months after kilovoltage therapy of facial basal cell carcinoma: A Danish national prospective study of 932 patients.
Journal: Scientific reports
Published: February 14, 2025
Failure pattern and salvage in head and neck cancer of unknown primary: A national study by DAHANCA.
Failure pattern and salvage in head and neck cancer of unknown primary: A national study by DAHANCA.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 07, 2025
Pembrolizumab as first-line treatment for recurrent and metastatic head and neck cancer - real-world single-centre data.
Journal: Acta oncologica (Stockholm, Sweden)
Published: September 30, 2024
Management of head and neck cancer of unknown primary: A phase IV study by DAHANCA.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 30, 2024
Impact of tumor subsite on survival outcomes in oral squamous cell carcinoma: A retrospective cohort study from 2000 to 2019.
Journal: Oral oncology
Published: November 08, 2023
A systematic review on clinical adaptive radiotherapy for head and neck cancer.
Journal: Acta oncologica (Stockholm, Sweden)
Published: August 10, 2023
The potential for local ablative therapy of oligometastases in head and neck squamous cell carcinoma: a real-world data analysis.
Journal: Acta oncologica (Stockholm, Sweden)
Published: August 07, 2023
A comparison of loco-regional relapse pattern in HPV positive vs negative oropharyngeal cancers following radiotherapy; relation to pretreatment FDG-PET and radiotherapy target volumes.
Journal: Acta oncologica (Stockholm, Sweden)
Published: July 25, 2023
Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma.
Journal: Viruses
Published: December 15, 2022
Efficacy of nivolumab as second line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a national DAHANCA cohort study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: August 01, 2022
Last Updated: 09/26/2026